Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, will be exhibiting at the International Food Ingredients & Additives (IFIA) Expo from May 22–24, 2024, at the Tokyo Big Sight Exhibition Center. The expo primarily focuses on functional foods, dietary supplements, and natural ingredient categories, and is a significant platform for food ingredient manufacturers.
Sabinsa’s technical and marketing team will be available in booth #1325, South Hall, to describe Sabinsa’s top-selling and trending products. Products to be featured at the expo include:
- Curcumin C3 Complex, obtained from the dried rhizomes of Curcuma longa and standardized for a minimum of 95% Curcuminoids.
- BioPerine, a natural bioavailability enhancer, standardized for minimum 95% Piperine.
- C3 Reduct, a cascading antioxidant with cumulatively stronger activity compared to parent Curcuminoids for maintaining organ health.
- LactoSpore, Bacillus coagulans MTCC 5856, the popular clinically validated, GRAS affirmed, shelf-stable probiotic.
- Saberry, a multifaceted phytonutrient from amla fruit standardized to the powerful antioxidant molecule beta-glucogallin, and clinically studied for blood sugar support.
Other Sabinsa products that are of major interest to formulators, such as Salaretin and Boswellin, will be on display at the expo.
Sabinsa will also host educational seminars on its novel ingredients that are gaining popularity in nootropic and weight management categories:
- On May 23, 2024, between 1:30 PM – 1: 45 PM, Taku Yoshiki, Senior General Manager, Sabinsa, will present the science behind its innovative ingredients that are used in nootropic applications, including Bacopin, Sabroxy, Centellin, Curcumin C3 Complex, etc.
- On May 24, 2024, between 2:30 PM – 2: 45 PM, Tatsuya Maruyama, Sales Manager, Sabinsa, will present the key ingredients from Sabinsa for diet and weight management, including Terminalia bellirica, Salaretin, Citrin, Garcitrin, and Fabenol.
At the event, Sabinsa will debut various prototype formulations, including White Curcuminoid Chewable tablets, LactoSpore and DigeZyme Chewable tablets, Curcumin C3 Complex gummies, and other innovative formulations. These prototypes are formulated to meet diverse health support applications, including immune support, digestive health, antioxidant and anti-inflammatory support, etc.
Shaheen Majeed, Global Managing Director and CEO of Sabinsa, stated, "I am looking forward to meeting with our Japanese partners and assisting them with our breakthrough solutions at the expo. I anticipate that the event will further strengthen our relationships with customers and add to Sabinsa’s growth momentum in Japan."
